Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tango Therapeutics (TNGX)
NASDAQ:TNGX
Tango Therapeutics (TNGX) Stock Price & Analysis
40 Followers
TNGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.47 - $11.61
Previous Close$11.26
Volume1.69M
Average Volume (3M)1.92M
Market Cap
$1.15B
Enterprise Value$873.96M
Total Cash (Recent Filing)$311.51M
Total Debt (Recent Filing)$39.89M
Price to Earnings (P/E)-9.3
Beta1.04
Next Earnings
Nov 08, 2023EPS Estimate
-$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.21
Shares Outstanding88,467,269
10 Day Avg. Volume1,313,891
30 Day Avg. Volume1,918,475
Standard Deviation0.30
R-Squared0.09
Alpha-0.00310
Financial Highlights & Ratios
Price to Book (P/B)4.52
Price to Sales (P/S)103.79
Price to Cash Flow (P/CF)-9.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue30.46
Enterprise Value/Gross Profit35.16
Enterprise Value/Ebitda-8.24
Forecast
1Y Price Target
$17.00Price Target Upside50.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Tango Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TNGX FAQ
What was Tango Therapeutics’s price range in the past 12 months?
Tango Therapeutics lowest stock price was $2.47 and its highest was $11.61 in the past 12 months.
What is Tango Therapeutics’s market cap?
Currently, no data Available
When is Tango Therapeutics’s upcoming earnings report date?
Tango Therapeutics’s upcoming earnings report date is Nov 08, 2023 which is in 37 days.
How were Tango Therapeutics’s earnings last quarter?
Tango Therapeutics released its earnings results on Aug 07, 2023. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.326 by $0.096.
Is Tango Therapeutics overvalued?
According to Wall Street analysts Tango Therapeutics’s price is currently Undervalued.
Does Tango Therapeutics pay dividends?
Tango Therapeutics does not currently pay dividends.
What is Tango Therapeutics’s EPS estimate?
Tango Therapeutics’s EPS estimate is -$0.34.
How many shares outstanding does Tango Therapeutics have?
Tango Therapeutics has 101,738,440 shares outstanding.
What happened to Tango Therapeutics’s price movement after its last earnings report?
Tango Therapeutics reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.326. Following the earnings report the stock price went up 1.176%.
Which hedge fund is a major shareholder of Tango Therapeutics?
Among the largest hedge funds holding Tango Therapeutics’s share is Baker Bros Advisors LP. It holds Tango Therapeutics’s shares valued at 2M.
---
Tango Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$17.00 (50.98% Upside)
$17.00 (50.98% Upside)
Hedge Fund Trend
Decreased
By 97.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.4M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
212.77%
12-Months-Change
Fundamentals
Return on Equity
-41.76%
Trailing 12-Months
Asset Growth
-15.40%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Tango Therapeutics
BCTG Acquisition Corp is a blank check company.
---
Top 5 ETFs holding TNGX
Vanguard Total Stock Market ETF
$11.04M
Schwab U.S. Broad Market ETF
$304.28K
iShares Russell 3000 ETF
$143.96K
Fidelity Nasdaq Composite Index ETF
$53.51K
Vanguard Russell 3000 ETF
$23.89K
Up to five ETFs with an Outperform Smart Score that hold TNGX. The ETFs are listed according to market value of TNGX within the ETF
---